Company Search:
Advanced Search
Sponsored Links
Newlink Genetics Corporation Company Snapshot
Newlink Genetics Corporation operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Newlink Genetics with three other companies in this sector in the United States: Orexigen Therapeutics Inc (2016 sales of $33.71 million of which 100% was Pharmaceuticals), Cumberland Pharmaceuticals Incorporation ($33.03 million of which 100% was Specialty Pharmaceutical Products), and Alimera Sciences, Incorporation ($34.33 million of which 100% was Medical Marketing).

Sales Analysis. Newlink Genetics reported sales of $35.77 million for the year ending December of 2016. This represents a sharp decrease of 47.8% versus 2015, when the company's sales were $68.50 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Newlink Genetics Corporation
  Stock Performance Chart for Newlink Genetics Corporation
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 8.62
(Figures in U.S. Dollars)
1 Week 0.5%   13 Weeks 4.7%  
4 Weeks -14.5%   52 Weeks -23.9%  
Newlink Genetics Corporation Key Data:
  Ticker: NLNK Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 35,768,000
(Year Ending Jan 2017).
Employees: 122
  Currency: U.S. Dollars Market Cap: 312,233,269
  Fiscal Yr Ends: December Shares Outstanding: 36,221,957
  Share Type: Common Closely Held Shares: 8,339,640
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.